CytomX Therapeutics Inc.

Company Listings from SPi: CytomX Therapeutics Inc.

You are here: Home >> SPi Company Listings >> CytomX Therapeutics Inc.

 

CytomX Therapeutics Inc.

Website:
http://

Search for other references to "cytomx" on SPi News

Latest CytomX Therapeutics Inc. News

CytomX to Present at the Cantor Fitzgerald Healthcare Conference SOUTH SAN FRANCISCO, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therape...... 21:05 GMT Wednesday 13th September 2017

CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call SOUTH SAN FRANCISCO, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeu...... 21:05 GMT Monday 7th August 2017

CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year Update SOUTH SAN FRANCISCO, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeu...... 13:00 GMT Thursday 27th July 2017

CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate   SOUTH SAN FRANCISCO, Calif., June 29, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeu...... 13:00 GMT Thursday 29th June 2017

CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial SOUTH SAN FRANCISCO, Calif., June 28, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeu...... 13:00 GMT Wednesday 28th June 2017

CytomX Therapeutics to Announce First Quarter 2017 Financial Results SOUTH SAN FRANCISCO, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therape...... 21:05 GMT Thursday 27th April 2017

CytomX Therapeutics Announces Teleconference and Webcast to Provide Corporate Update SOUTH SAN FRANCISCO, Calif., March 19, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therape...... 23:00 GMT Sunday 19th March 2017

CytomX Announces Full-Year 2016 Financial Results SOUTH SAN FRANCISCO, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therape...... 21:05 GMT Thursday 2nd March 2017

CytomX Therapeutics to Announce Full-Year 2016 Financial Results SOUTH SAN FRANCISCO, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therape...... 13:00 GMT Wednesday 1st March 2017

CytomX Therapeutics to Present at Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeu...... 21:05 GMT Tuesday 21st February 2017

Buy CytomX Therapeutics Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers